NEW YORK, June 6-Variagenics said today that it has been granted a U.S. patent for its computational method for SNP identification.
The patent, granted June 4, covers Variagenics' proprietary technique for discovering unknown polymorphisms in genes that appear to be relevant to disease. Their "sequence scanning" method allows company researchers to more easily distinguish SNPs from sequence data.
Variagenics, based in Cambridge, Mass., is a pharmacogenomic and diagnostic company. It plans to use the data generated from its SNP studies in improving drug development and creating new pharmacogenomic diagnostics.
For more information, see the patent.